Page 5 - Jayasree Iyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making common infectious diseases such as pneumonia, tuberculosis and gonorrhoea harder to treat. Jayasree Iyer, executive director of the Access to Medicine Foundation, said: “Small and medium-sized companies are very critical for antimicrobial research. Big pharma has been leaving this space – only a small handful of companies are still developing drugs.” Big pharma is also involved in the $1bn AMR Action Fund, a collaboration with the WHO, European Investment Bank and Wellcome Trust, which was launched last July to support clinical-stage antibiotic research and aims to bring two to four new antibiotics to market by 2030.

United kingdomNoord hollandJayasree iyerAction fundAccess to medicine foundationEuropean investment bankMedicine foundationWellcome trustஒன்றுபட்டது கிஂக்டம்நூற்த் ஹாலண்ட்ஜெயஸ்ரீ இயேற்நடவடிக்கை நிதிநுழைவு க்கு மருந்து அடித்தளம்ஐரோப்பிய முதலீடு வங்கிமருந்து அடித்தளம்வெல்கம் நம்பிக்கை